Meanwhile, triple-negative breast cancer (TNBC) lacking the expression of estrogen and progesterone receptors and ERBB2 is a heterogeneous tumor that encompasses several molecular subtypes of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.